ATAI Life Sciences NV (ATAI)
1.28
-0.07
(-5.19%)
USD |
NASDAQ |
Nov 14, 12:32
ATAI Life Sciences Debt to Equity Ratio: 0.1105 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.1105 |
| March 31, 2024 | 0.0883 |
| December 31, 2023 | 0.0736 |
| September 30, 2023 | 0.0577 |
| June 30, 2023 | 0.0719 |
| March 31, 2023 | 0.0642 |
| December 31, 2022 | 0.058 |
| Date | Value |
|---|---|
| September 30, 2022 | 0.0518 |
| June 30, 2022 | 0.002 |
| March 31, 2022 | 0.0021 |
| December 31, 2021 | 0.002 |
| September 30, 2021 | 0.0018 |
| June 30, 2021 | 0.0026 |
| March 31, 2021 | 0.0266 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0018
Minimum
Sep 2021
0.1105
Maximum
Jun 2024
0.0438
Average
0.0548
Median
Debt to Equity Ratio Benchmarks
| Affimed NV | 0.3286 |
| InflaRx NV | 0.00 |
| BioNTech SE | 0.0127 |
| Immatics NV | 0.00 |
| CureVac NV | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 215.78M |
| Total Liabilities (Quarterly) | 47.24M |
| Shareholders Equity (Quarterly) | 167.89M |
| Current Ratio | 6.683 |
| Net Debt Paydown Yield | -0.30% |